Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Carcinoma|Malignant Neoplasm of Breast
Interventions: BIOLOGICAL: Mammaglobin-A DNA Vaccine|PROCEDURE: Optional biopsy
Sponsor: Washington University School of Medicine
Collaborators: Rising Tide Foundation|United States Department of Defense